Laxatives Market

Market Insights

Constipation is one of the most commonly occurring gastrointestinal disorders, the prevalence of which is between 0.7% and 79% (with a median at 16%) across adults and children, including all regions. The variability of constipation prevalence is significantly wide, subject to gender, demographics, race, age, diet, and other factors. Due to its alarming chronicity and high prevalence, management of constipation often comes with substantial healthcare costs, nursing time, and also the debilitating effect on the quality of life. The development of medications for the treatment of constipation has been an age-old process in pharmacology, and several products have been introduced into the market even before drug commercialization regulations evolved.

This report is a comprehensive research study of the global laxatives market that elaborates on the major trends in the market based on quantitative and qualitative research. This report provides a detailed description of the global laxatives market, segmenting the market by drugs and geography. This report aids the market stakeholders in making improved decisions and strategies in the retinal vein occlusion therapeutics market.

For the research purpose, the global laxatives market is segmented on the basis of drugs and geography. On the basis of drugs, the global laxatives market is segmented into psyllium, docusate, bisacodyl, senna, polyethylene glycol 3350, methylcellulose, and others. This report presents the market size from 2016 to 2026, considering 2017 as the base for the analysis. CAGRs are calculated for the forecast period from 2018 to 2026.

On the basis of geographical distribution, the market size of the global laxatives market is provided for the period 2016-2026, and CAGRs are considered for the forecast period from 2018 to 2026. Moreover, geographical regions are also studied by sub-segmenting in terms of drug types and constituent countries.

This report thoroughly describes the key market trends, insights, and market drivers and restraints to aid in a comprehensive understanding of the global laxatives market. Along with the quantitative market estimates, qualitative market assessment factors are also provided in the report, including attractive investment propositions in geography and drug segmentation. Further, the competitive landscape is mapped graphically based on the product offering and business strength of the organizations, including pipeline products. Along with the competitive landscape, each player is profiled in the report for their business details, product portfolio, financial details, and major news coverage. Key players that are profiled in the report include Bayer AG, Boehringer Ingelheim Pharmaceuticals, Inc., Braintree Laboratories, Inc., GlaxoSmithKline Plc, and Procter & Gamble Company, Purdue Pharma L.P., and Sucampo Pharmaceuticals, Inc.

Based on the drug types, the global laxatives market is segmented as follows:

• Psyllium
• Docusate
• Bisacodyl
• Senna
• Polyethylene Glycol 3350
• Methylcellulose
• Others 

Constipation can be treated with home remedies such as adding fiber to the diet, regular exercise, and increasing the intake of fluids. Home remedies are effective in the treatment of mild cases of constipation. However, laxatives are the drugs that are utilized to treat severe as well as mild cases of constipation. These laxatives have different mechanisms to cure constipation and have distinct variations from one drug to another. Drug classes, including psyllium and methylcellulose, act by increasing the bulk in the stool, creating an outcome that causes the movement of the intestines. Hence, these drug classes are also known as bulk-forming laxatives. Furthermore, a few drugs work by cumulating the volume of water in the stool, creating the stool laxer and easier to pass. Drug compounds such as senna and bisacodyl are known as stimulant laxatives. Stimulant laxatives work by inducing a bowel movement by acting to speed up colonic muscle movement.

Increasing awareness and adoption of laxatives in the market and approval of pipeline products are the factors responsible for the market growth. The global laxatives market is emerging at a considerable pace because of the high prevalence of constipation and more research and development activities involved.

Geographically, the global laxatives market is cumulative to Latin America, Asia Pacific, North America, Middle East, Africa, and Europe.

For geographical analysis, the global laxatives market is categorized into five major regional markets, North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. Among these regions, North America dominated the market in the year 2017. The strong existence of all the major Rx and OTC laxative drugs, higher consciousness about constipation, and its rapid treatment are the main factors contributing to the prominent position of not only laxatives but the overall digestive remedies drugs market in North America. On regional assessment, most of the market opportunities are possessed by the Asia Pacific. The Asia Pacific is anticipated to surge at a faster pace due to factors such as the rising prevalence of constipation and increasing healthcare investment in the region.

The thorough geographical categorization of the global laxatives market is as follows:

• North America (U.S. & Canada)
• Asia Pacific (Japan, China, and Rest of Asia Pacific)
• Europe (Germany, U.K., and Rest of Europe)
• Latin America (Mexico, Brazil, and Rest of Latin America)
• The Middle East and Africa (GCC and Rest of the Middle East and Africa)

Chapter 1. Preface
1.1. Report Scope and Description
1.2. Research Methodology
1.2.1. Phase I-Secondary Research
1.2.2. Phase II-Primary Research
1.2.3. Phase III-Expert Panel Review
1.2.4. Assumptions
1.2.5. Approach Adopted

Chapter 2. Executive Summary
2.1. Global Laxatives Market Portraiture
2.2. Global Laxatives Market, by Drug Type, 2017 (US$ Mn)
2.3. Global Laxatives Market, by Geography, 2017 (US$ Mn)

Chapter 3. Laxatives Market Analysis
3.1. Laxatives Market Overview
3.2. Market Dynamics
3.2.1. Market Drivers
3.2.1.1. Lifestyle Trends Increase the Risk of Constipation thus Consumption of Laxatives
3.2.1.2. Higher Prevalence of Constipation in Geriatric Population
3.2.2. Challenges
3.2.2.1. Demographic Reservations to Impact the Market
3.2.3. Opportunities
3.2.3.1. Emerging Markets Present Lucrative Opportunity for Growth
3.3. Attractive Investment Proposition, by Geography, 2017
3.4. Competitive Landscape, by Key Players, 2017

Chapter 4. Global Laxatives Market, by Drug Type, 2016-2026 (US$ Mn)
4.1. Preface
4.1.1. Attractive Investment Proposition, by Drug Type, 2017
4.2. Senna
4.3. Bisacodyl
4.4. Docusate
4.5. Polyethylene Glycol 3350
4.6. Psyllium
4.7. Methylcellulose
4.8. Others
4.9. Phase Analysis (Market estimations by 2026)
4.9.1. Projected Sale of Phase III Drugs Estimated Till 2026 (US$ Mn)
4.9.1.1. BLI801
4.9.1.2. AJG555
4.9.1.3. Elobixibat
4.9.1.4. Tenapanor
4.9.2. Qualitative Information on Phase II and I drugs

Chapter 5. Global Laxatives Market, by Geography, 2016 – 2026 (US$ Mn)
5.1. Overview
5.2. North America Laxatives Market Analysis, 2016 – 2026 (US$ Mn)
5.2.1. North America Laxatives Market, by Drug Type, 2016 – 2026 (US$ Mn)
5.2.2. North America Laxatives Market, by Country, 2016 – 2026 (US$ Mn)
5.2.2.1. U.S.
5.2.2.2. Canada
5.3. Europe Laxatives Market Analysis, 2016 – 2026 (US$ Mn)
5.3.1. Europe Laxatives Market, by Drug Type, 2016 – 2026 (US$ Mn)
5.3.2. Europe Laxatives Market, by Country, 2016 – 2026 (US$ Mn)
5.3.2.1. U.K.
5.3.2.2. Germany
5.3.2.3. Rest of Europe
5.4. Asia Pacific Laxatives Market Analysis, 2016 – 2026 (US$ Mn)
5.4.1. Asia Pacific Laxatives Market, by Drug Type, 2016 – 2026 (US$ Mn)
5.4.2. Asia Pacific Laxatives Market, by Country, 2016 – 2026 (US$ Mn)
5.4.2.1. China
5.4.2.2. Japan
5.4.2.3. Rest of APAC
5.5. Latin America Laxatives Market Analysis, 2016 – 2026 (US$ Mn)
5.5.1. Latin America Laxatives Market, by Drug Type, 2016 – 2026 (US$ Mn)
5.5.2. Latin America Laxatives Market, by Country, 2016 – 2026 (US$ Mn)
5.5.2.1. Brazil
5.5.2.2. Mexico
5.5.2.3. Rest of Latin America
5.6. Middle East & Africa (MEA) Laxatives Market Analysis, 2016 – 2026 (US$ Mn)
5.6.1. MEA Laxatives Market, by Drug Type, 2016 – 2026 (US$ Mn)
5.6.2. MEA Laxatives Market, by Country, 2016 – 2026 (US$ Mn)
5.6.2.1. GCC
5.6.2.2. Rest of MEA

Chapter 6. Company Profiles
6.1. Bayer AG
6.1.1. Business Description
6.1.2. Financial Information (Subject to data availability)
6.1.3. Application Portfolio
6.1.4. Key Developments
6.2. Boehringer Ingelheim Pharmaceuticals, Inc.
6.3. Braintree Laboratories, Inc.
6.4. GlaxoSmithKline Consumer Healthcare, L.P.
6.5. Procter & Gamble Company
6.6. Purdue Pharma L.P.
6.7. Sucampo Pharmaceuticals, Inc.

List Of Figures

FIG. 1 Laxatives Market: Research Methodology
FIG. 2 Global Laxatives Market, by Drug Type, 2017 (US$ Mn)
FIG. 3 Global Laxatives Market, by Geography, 2017 (US$ Mn)
FIG. 4 Attractive Investment Proposition, by Geography, 2017
FIG. 5 Market Competition Landscape, by Key Players, 2017
FIG. 6 Attractive Investment Proposition, by Drug Type, 2017
FIG. 7 Global Senna Market for Laxatives, 2016 – 2026 (US$ Mn)
FIG. 8 Global Bisacodyl Market for Laxatives, 2016 – 2026 (US$ Mn)
FIG. 9 Global Docusate Market for Laxatives, 2016 – 2026 (US$ Mn)
FIG. 10 Global Polyethylene Glycol 3350 Market for Laxatives, 2016 – 2026 (US$ Mn)
FIG. 11 Global Psyllium Market for Laxatives, 2016 – 2026 (US$ Mn)
FIG. 12 Global Methylcellulose Market for Laxatives, 2016 – 2026 (US$ Mn)
FIG. 13 Global Others Market for Laxatives, 2016 – 2026 (US$ Mn)
FIG. 14 Global BLI801 Market for Laxatives, till 2026 (US$ Mn)
FIG. 15 Global AJG555 Market for Laxatives, till 2026 (US$ Mn)
FIG. 16 Global Elobixibat Market for Laxatives, till 2026 (US$ Mn)
FIG. 17 Global Tenapanor Market for Laxatives, till 2026 (US$ Mn)
FIG. 18 U.S. Laxatives Market, 2016 – 2026 (US$ Mn)
FIG. 19 Canada Laxatives Market, 2016 – 2026 (US$ Mn)
FIG. 20 U.K. Laxatives Market, 2016 – 2026 (US$ Mn)
FIG. 21 Germany Laxatives Market, 2016 – 2026 (US$ Mn)
FIG. 22 Rest of Europe Laxatives Market, 2016 – 2026 (US$ Mn)
FIG. 23 China Laxatives Market, 2016 – 2026 (US$ Mn)
FIG. 24 Japan Laxatives Market, 2016 – 2026 (US$ Mn)
FIG. 25 Rest of Asia Pacific Laxatives Market, 2016 – 2026 (US$ Mn)
FIG. 26 Brazil Laxatives Market, 2016 – 2026 (US$ Mn)
FIG. 27 Mexico Laxatives Market, 2016 – 2026 (US$ Mn)
FIG. 28 Rest of Latin America Laxatives Market, 2016 – 2026 (US$ Mn)
FIG. 29 GCC Laxatives Market, 2016 – 2026 (US$ Mn)
FIG. 30 Rest of Middle East and Africa Laxatives Market, 2016 – 2026 (US$ Mn)

List Of Table

TABLE 1 Global Laxatives Market Portraiture
TABLE 2 Global Laxatives Market, by Drug Type, 2016 – 2026 (US$ Mn)
TABLE 3 Global Pipeline Analysis Market for Laxatives, Till 2026 (US$ Mn)
TABLE 4 Global Laxatives Market, by Geography, 2016 – 2026 (US$ Mn)
TABLE 5 North America Laxatives Market, by Drug Type, 2016 – 2026 (US$ Mn)
TABLE 6 North America Laxatives Market, by Country, 2016 – 2026 (US$ Mn)
TABLE 7 Europe Laxatives Market, by Drug Type, 2016 – 2026 (US$ Mn)
TABLE 8 Europe Laxatives Market, by Country, 2016 – 2026 (US$ Mn)
TABLE 9 Asia Pacific Laxatives Market, by Drug Type, 2016 – 2026 (US$ Mn)
TABLE 10 Asia Pacific Laxatives Market, by Country, 2016 – 2026 (US$ Mn)
TABLE 11 Latin America Laxatives Market, by Drug Type, 2016 – 2026 (US$ Mn)
TABLE 12 Latin America Laxatives Market, by Country, 2016 – 2026 (US$ Mn)
TABLE 13 Middle East and Africa Laxatives Market, by Drug Type, 2016 – 2026 (US$ Mn)
TABLE 14 Middle East and Africa Laxatives Market, by Region, 2016 – 2026 (US$ Mn)
TABLE 15 Bayer AG: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 16 Boehringer Ingelheim Pharmaceuticals, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 17 Braintree Laboratories, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 18 GlaxoSmithKline Plc: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 19 Procter & Gamble Company: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 20 Purdue Pharma L.P.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 21 Sucampo Pharmaceuticals, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)